Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26841680.
- Also identified by DOI 10.1038/ncomms10517 and PMC identifier 4742920.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) expand in the spleen during cancer and promote progression through suppression of cytotoxic T cells. An anti-inflammatory reflex arc involving the vagus nerve and memory T cells is necessary for resolution of acute inflammation. Failure of this neural circuit could promote procarcinogenic inflammation and altered tumour immunity. Here we show that splenic TFF2, a secreted anti-inflammatory peptide, is released by vagally modulated memory T cells to suppress the expansion of MDSCs through CXCR4. Splenic denervation interrupts the anti-inflammatory neural arc, resulting in the expansion of MDSCs and colorectal cancer. Deletion of Tff2 recapitulates splenic denervation to promote carcinogenesis. Colorectal carcinogenesis could be suppressed through transgenic overexpression of TFF2, adenoviral transfer of TFF2 or transplantation of TFF2-expressing bone marrow. TFF2 is important to the anti-inflammatory reflex arc and plays an essential role in arresting MDSC proliferation. TFF2 offers a potential approach to prevent and to treat cancer.
Medical subject headings
- Cell Proliferation
- Colitis
- Colorectal Neoplasms
- Mucins
- Muscle Proteins
- Myeloid Cells
- Peptides
- Receptors, CXCR4
- Spleen
- T-Lymphocytes, Cytotoxic
- Vagus Nerve